There is a lot that goes into starting a clinical or population research study. In fact, many of these studies can take years to get off the ground. Not to mention recruiting, which is a task in and of itself. Given the difficulties surrounding the rigorous process ahead of those embarking upon these studies, the University of Texas at Austin’s Dell Medical School is providing research study teams with a roadmap for research success. The Nuts and Bolts of Executing a Clinical or Population Research Study is a virtual series that helps lay the groundwork and give researchers the tools to make a positive impact in healthcare.
About the ‘Nuts and Bolts’ Program
The series consists of one-hour discussion forums spanning several topics aligned with running a ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
The NCI Community Oncology Research Program: Opportunities to Increase Latino Participation in Clinical Trials
Dr. Brenda Adjei is Associate Director of the HDRP at the National Cancer Institute (NCI) Center for Cancer Research. The NCI Community Oncology Research Program Dr. Adjei’s presentation began with a discussion of Latino participation in cancer clinical trials. Variety in clinical trials is critically important because it generates biomedical knowledge relevant to all, builds trust and trustworthiness, and contributes to reductions in health gaps and fair research participation. Current limits in clinical research is due to multilevel hurdles and requires tailored, ...
In 2024, an estimated 195,300 cancer cases will be diagnosed in U.S. Latinos, according to Cancer Facts & Figures for Hispanic/Latino People 2024-2026. This makes it important that cancer treatments work for Latinos. Clinical trials – studies with volunteers that explore ways to find, prevent, and treat diseases, like cancer – are a treatment option that could help people. With clinical trial participation in mind, Dr. Eneida Nemecek and her team at the Oregon Health and Science University (OHSU) Knight Cancer Institute created Proyecto Mi Opción, a series of Spanish-language videos that tackle different cancer-related topics. Watch the videos!
The Lack of Latinos in Clinical Trial Research
Latinos face several challenges when it comes to cancer including access to ...
As a child in Arecibo, Puerto Rico, Dr. Eneida Nemecek learned the effort it takes to earn an education by literally going to college with her parents as they sought their degrees. “My parents are very young. I kind of went to college with both of them in the back of the classroom,” Nemecek said. “My dad ended up going to graduate school, also when I was still a little kid. We went to law school with him, too.” Nemecek followed her parents’ footsteps and eventually got her doctoral degree. Today she’s helping improve Latino health through clinical trial participation as associate director for clinical research at the Oregon Health & Science University (OHSU) Knight Cancer Institute and professor of pediatrics and medical oncology at OHSU.
Developing a Passion for ...
Our collaborative bilingual video that focuses on Latino participation in clinical trials was a "Silver Winner" at both the 2024 W³ Awards and the 45th Annual Telly Awards! The video, created by Genentech with help from the Institute for Health Promotion Research at UT Health San Antonio, the team behind Salud America!, shows why Latino participation in clinical trials is important for the future of clinical research. Clinical trials are studies with volunteers that can help researchers learn how to slow, manage, and treat different cancer and disease. “The lack of Latinos in clinical trials makes it hard for researchers to develop new treatments for this group, which suffers a heavy burden of cancer,” said Dr. Amelie Ramirez, director of Salud America! and the Institute ...
Latinos and other group that experience health differences are frequently left out in spine pain clinical trials, according to an analysis from eight randomized controlled trials (RCTs). The study, published by National Institute of Health and funded by the National Center for Complimentary and Integrative Health, found a lack of participation among vulnerable populations and other overlooked groups. Let’s look further into the data and how it impacts Latinos.
Participation in Clinical Trials on Spinal Pain
The analysis points out that, while RCTs are considered the gold standard study design for evaluating treatment effectiveness, they can suffer from generalizability issues. In other words, the findings of these studies can’t be generalized to the U.S. population because ...
The last thing a person wants to hear from their doctor is “You have cancer.” Unfortunately, that’s the reality for the thousands of Americans, including many Latinos, diagnosed with cancer each year. After a diagnosis, people dealing with cancer discuss treatment options with their medical care team, which may include participation in clinical trials. Clinical trials are studies with volunteers that test ways to find, prevent, and treat cancer and other diseases. They may also help improve the quality of life for volunteers affected by cancer or reduce the side effects of treatment. Despite the benefits of participating in clinical trials, only about one out of every five (21.9%) people with cancer enroll in clinical research, according to a new study in the ...
Clinical trials have led to the development of better treatments, life-saving medicines, and new prevention strategies for cancer and other diseases. Still, clinical trials have lacked volunteers who are Latino. We need a variety of participants in clinical trials to ensure health and medical discoveries are fair for all populations. To promote clinical trials, let’s use #SaludTues on Tuesday, Dec. 5, 2023, to discuss reasons why Latinos and all people should consider joining a clinical trial! WHAT: #SaludTues Tweetchat: Why Should You Try a Clinical Trial?
TIME/DATE: 1-2 p.m. ET (Noon-1 p.m. CT), Tuesday, Dec. 5, 2023
WHERE: On Twitter with hashtag #SaludTues
HOST: @SaludAmerica
CO-HOSTS: LatinaStrong Foundation (@LatinaStrongDr); Public Health Maps ...
Most people with COVID-19 get better within a few days to a few weeks after COVID-19 infection. But some people, including many Latinos, develop long COVID. Long COVID remains an unresolved threat to the health of Latinos and all people. While health experts don’t yet fully understand long COVID symptoms and risk factors, progress is being made regarding treatment. Let’s learn more about how researchers are working to find the most effective therapies for long COVID through research studies and clinical trials.
Relieving the Burden of Long COVID Symptoms
The National Institutes of Health (NIH) launched the RECOVER research study in 2021 to learn why some people experience long COVID or develop new or returning symptoms after COVID-19 infection. Now, based on ...
